Today: 16 April 2026
VNET Group stock price jumps in premarket after Jefferies call; what investors watch next
12 February 2026
1 min read

VNET Group stock price jumps in premarket after Jefferies call; what investors watch next

New York, Feb 12, 2026, 09:24 EST — Premarket

  • VNET shares pushed higher, stretching their rally just before the Nasdaq bell.
  • Jefferies’ note kept the spotlight on the China data-center ADR.
  • Investors want answers on power capacity, major customer deals, and how the company plans to fund operations.

VNET Group, Inc’s U.S. shares (VNET.O) added 3.6% in premarket action Thursday, ticking up to $14.03. That move followed a sharp 12.2% rally on Wednesday, which took the stock to $13.54. Trading volumes spiked as well, with nearly 12.5 million shares changing hands—about twice what moved the day before.

VNET’s sharp move has shoved the stock back into the AI-infrastructure spotlight. Data-center operators aren’t just chasing clients—electricity supply and ready-to-go space are just as critical, since contracts typically depend on the wattage a facility can provide.

This stock reacts fast to even minor headlines. Fresh details on power capacity or a big client win can upend forecasts for spending, project timing, and margins. Traders now have an eye on whether Wednesday’s jump sticks once after-hours trading begins.

StreetInsider reported that Jefferies’ Edison Lee is sticking with his Buy call on VNET, leaving the price target steady at $27.22 this Tuesday.

Jefferies noted VNET had locked in over 100 megawatts of extra power capacity in Ulanqab and sees a likely announcement soon: the company could be landing a hyperscaler contract ranging from 150 to 250 megawatts, according to Investing.com.

“Hyperscaler” refers to a major cloud or internet firm snapping up massive amounts of data-center space in bulk. In this business, the megawatt stands in as the go-to measure—essentially shorthand for the total IT load a site can handle.

VNET, the Chinese IDC operator, last posted earnings in November. Third-quarter net revenue climbed 21.7% from a year earlier and the company raised its full-year outlook. “We delivered another strong quarter,” interim CEO Josh Sheng Chen said, highlighting growing AI-fueled demand. PR Newswire

The news puts renewed focus on other U.S.-listed China data-center stocks, which investors typically use as stand-ins for trends in local cloud and AI investment. Sentiment can turn sharply on even small signals.

Still, it’s a precarious position. Simply Wall St points out that the company has under a year’s worth of cash runway, which throws the spotlight back onto funding and execution risks just as new capacity comes online.

Traders are eyeing VNET to see if it can keep its footing above $14 after the bell. The focus: any new disclosures that might lend weight to chatter about power expansion and a big customer in the mix.

The real test comes with VNET’s fourth-quarter earnings, due March 11, Public.com shows. Contract wins, capex details, and VNET’s funding plans for upcoming expansion—all on the docket for investors.

Stock Market Today

  • Flow Traders Shares Show Short-Term Momentum Amid Valuation Debate
    April 15, 2026, 10:09 PM EDT. Flow Traders (ENXTAM:FLOW) shares rose 2% over the past week and 12.8% year-to-date, despite a 7.8% decline in total shareholder return over one year. The stock currently trades at €28.54, slightly below a consensus analyst price target of €30.07, suggesting a potential undervaluation of about 31%. Analysts forecast revenue of €681.1 million and earnings of €186.9 million by 2029, implying a price-to-earnings ratio of 9.6x, based on a 10.4% discount rate. However, risks include possible reversals in digital asset gains and rising fixed expenses that could pressure margins. Investors must weigh these factors carefully amid shifting growth prospects. Flow Traders' short-term momentum contrasts with mixed longer term returns, making valuation and earnings assumptions key to further investment decisions.

Latest article

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
Taylor Wimpey share price ticks up as Help to Buy talk keeps UK builders in play
Previous Story

Taylor Wimpey share price ticks up as Help to Buy talk keeps UK builders in play

Vertiv stock extends rally on surging data-center orders; investors eye next catalysts
Next Story

Vertiv stock extends rally on surging data-center orders; investors eye next catalysts

Go toTop